165 related articles for article (PubMed ID: 3370988)
41. Studies with cyproterone acetate for male contraception.
Roy S; Chatterjee S
J Steroid Biochem; 1979 Jul; 11(1B):675-80. PubMed ID: 491632
[TBL] [Abstract][Full Text] [Related]
42. In vitro steroid metabolic studies in human testes I: Effects of estrogen on progesterone metabolism.
Rodriguez-Rigau LJ; Tcholakian RK; Smith KD; Steinberger E
Steroids; 1977 Jun; 29(6):771-86. PubMed ID: 910250
[TBL] [Abstract][Full Text] [Related]
43. Developments in male contraception.
Bialy G; Alexander NJ
Health Sex; 1992; 3(2):10-1. PubMed ID: 12286189
[TBL] [Abstract][Full Text] [Related]
44. Effects of chronic testosterone administration in normal men: safety and efficacy of high dosage testosterone and parallel dose-dependent suppression of luteinizing hormone, follicle-stimulating hormone, and sperm production.
Matsumoto AM
J Clin Endocrinol Metab; 1990 Jan; 70(1):282-7. PubMed ID: 2104626
[TBL] [Abstract][Full Text] [Related]
45. Administration of norethandrolone and testosterone as a contraceptive agent for men.
Brenner PF; Bernstein GS; Roy S; Jecht EW; Mishell DR
Contraception; 1975 Feb; 11(2):193-207. PubMed ID: 1112088
[TBL] [Abstract][Full Text] [Related]
46. Gonadotropin-releasing hormone antagonist plus testosterone: a potential male contraceptive.
Bremner WJ; Bagatell CJ; Steiner RA
J Clin Endocrinol Metab; 1991 Sep; 73(3):465-9. PubMed ID: 1874925
[TBL] [Abstract][Full Text] [Related]
47. Comparison of the effects of contraceptive steroid formulations containing two doses of estrogen on pituitary function.
Scott JZ; Kletzky OA; Brenner PF; Mishell DR
Fertil Steril; 1978 Aug; 30(2):141-5. PubMed ID: 98356
[TBL] [Abstract][Full Text] [Related]
48. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
Scott JA; Brenner PF; Kletzky OA; Mishell DR
Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
[TBL] [Abstract][Full Text] [Related]
49. Phenoxybenzamine--an effective male contraceptive pill.
Homonnai ZT; Shilon M; Paz GF
Contraception; 1984 May; 29(5):479-91. PubMed ID: 6430643
[TBL] [Abstract][Full Text] [Related]
50. Depot gonadotropin-releasing hormone agonist blunts the androgen-induced suppression of spermatogenesis in a clinical trial of male contraception.
Behre HM; Nashan D; Hubert W; Nieschlag E
J Clin Endocrinol Metab; 1992 Jan; 74(1):84-90. PubMed ID: 1727833
[TBL] [Abstract][Full Text] [Related]
51. Low dose of cyproterone acetate and testosterone enanthate for contraception in men.
Meriggiola MC; Bremner WJ; Costantino A; Di Cintio G; Flamigni C
Hum Reprod; 1998 May; 13(5):1225-9. PubMed ID: 9647551
[TBL] [Abstract][Full Text] [Related]
52. Comparison of a gonadotropin releasing-hormone antagonist plus testosterone (T) versus T alone as potential male contraceptive regimens.
Bagatell CJ; Matsumoto AM; Christensen RB; Rivier JE; Bremner WJ
J Clin Endocrinol Metab; 1993 Aug; 77(2):427-32. PubMed ID: 8345047
[TBL] [Abstract][Full Text] [Related]
53. Effects of gossypol on human and monkey sperm motility in vitro.
Chongthammakun S; Ekavipat C; Sanitwongse B; Pavasuthipaisit K
Contraception; 1986 Sep; 34(3):323-31. PubMed ID: 3791997
[TBL] [Abstract][Full Text] [Related]
54. Studies on the male antifertility agent-gossypol acetic acid. II. Effect of gossypol acetic acid on the motility and ATPase activity of human spermatozoa.
Kalla NR; Vasudev M
Andrologia; 1981; 13(2):95-8. PubMed ID: 6454365
[TBL] [Abstract][Full Text] [Related]
55. Pituitary and ovarian responsiveness to a graded gonadotropin releasing factor stimulation test in women using a low-estrogen or a regular type of oral contraceptive.
Spellacy WN; Kalra PS; Buhi WC; Birk SA
Am J Obstet Gynecol; 1980 May; 137(1):109-15. PubMed ID: 6768295
[TBL] [Abstract][Full Text] [Related]
56. The search for male contraception. Men are different.
Steinmann M
RF Illus; 1982 Jun; ():29-31. PubMed ID: 12264477
[TBL] [Abstract][Full Text] [Related]
57. Sex hormone profiles in oligomenorrheic adolescent girls and the effect of oral contraceptives.
Siegberg R; Nilsson CG; Stenman UH; Widholm O
Fertil Steril; 1984 Jun; 41(6):888-93. PubMed ID: 6233177
[TBL] [Abstract][Full Text] [Related]
58. [The antifertility effect of gossypol plus testosterone and estrogen].
Ye WS; Dan L; Guo Y; Qian XJ; Ying J; Xue SP
Yao Xue Xue Bao; 1996; 31(4):313-5. PubMed ID: 9208651
[TBL] [Abstract][Full Text] [Related]
59. Study of medroxyprogesterone acetate and testosterone enanthate as a male contraceptive.
Brenner PF; Mishell DR; Bernstein GS; Ortiz A
Contraception; 1977 Jun; 15(6):679-91. PubMed ID: 891194
[TBL] [Abstract][Full Text] [Related]
60. Testicular suspension as a method of male contraception: technique and results.
Shafik A
Adv Contracept Deliv Syst; 1991; 7(3-4):269-79. PubMed ID: 12284770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
